Abstract | BACKGROUND AND PURPOSE: The BEST-MSU study (Benefits of Stroke Treatment Delivered Using a Mobile Stroke Unit) is a comparative effectiveness trial in patients randomized to mobile stroke unit or standard management. A substudy tested interrater agreement for tissue-type plasminogen activator eligibility between a telemedicine vascular neurologist and onboard vascular neurologist. METHODS: On scene, both the telemedicine vascular neurologist and onboard vascular neurologist independently evaluated the patient, documenting their tissue-type plasminogen activator treatment decision, National Institutes of Health Stroke Scale score, and computed tomographic interpretation. Agreement was determined using Cohen κ statistic. Telemedicine-related technical failures that impeded remote assessment were recorded. RESULTS: Simultaneous and independent telemedicine vascular neurologist and onboard vascular neurologist assessment was attempted in 174 patients. In 4 patients (2%), the telemedicine vascular neurologist could not make a decision because of technical problems. The telemedicine vascular neurologist agreed with the onboard vascular neurologist on 88% of evaluations (κ=0.73). CONCLUSIONS: Remote telemedicine vascular neurologist assessment is reliable and accurate, supporting either telemedicine vascular neurologist or onboard vascular neurologist assessment on our mobile stroke unit. CLINICAL TRIAL REGISTRATION: URL: http://www.clinicaltrials.gov. Unique identifier: NCT02190500.
|
Authors | Tzu-Ching Wu, Stephanie A Parker, Amanda Jagolino, Jose-Miguel Yamal, Ritvij Bowry, Abraham Thomas, Amy Yu, James C Grotta |
Journal | Stroke
(Stroke)
Vol. 48
Issue 2
Pg. 493-496
(02 2017)
ISSN: 1524-4628 [Electronic] United States |
PMID | 28082671
(Publication Type: Journal Article, Randomized Controlled Trial, Research Support, Non-U.S. Gov't)
|
Copyright | © 2017 American Heart Association, Inc. |
Chemical References |
- Tissue Plasminogen Activator
|
Topics |
- Aged
- Aged, 80 and over
- Emergency Medical Services
(methods, trends)
- Female
- Humans
- Male
- Middle Aged
- Mobile Health Units
(trends)
- Neurologists
(trends)
- Pilot Projects
- Stroke
(diagnostic imaging, therapy)
- Telemedicine
(methods, trends)
- Tissue Plasminogen Activator
(administration & dosage)
- Tomography, X-Ray Computed
|